John P. Fruehauf, MD, UC Irvine Health, explains how 50% of Melanoma Patients Develop Brain Metastases | BRAF-MEK & Immunotherapy Help Brain Metastases at MOASC 2018
50% of Melanoma Patients Develop Brain Metastases | BRAF-MEK & Immunotherapy Help Brain Metastases
